These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 29080234)

  • 1. An improved model for the analysis of combined antimicrobials: a replacement for the Chou-Talalay combination index method.
    Anastasiadi M; Polizzi K; Lambert RJW
    J Appl Microbiol; 2018 Jan; 124(1):97-107. PubMed ID: 29080234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the effect of combined antimicrobials: A base model for multiple-hurdles.
    Anastasiadi M; Lambert RJW
    Int J Food Microbiol; 2017 Jul; 252():10-17. PubMed ID: 28436829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model for the efficacy of combined inhibitors.
    Lambert RJ; Lambert R
    J Appl Microbiol; 2003; 95(4):734-43. PubMed ID: 12969287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug combination studies and their synergy quantification using the Chou-Talalay method.
    Chou TC
    Cancer Res; 2010 Jan; 70(2):440-6. PubMed ID: 20068163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method.
    Zhang N; Fu JN; Chou TC
    Am J Cancer Res; 2016; 6(1):97-104. PubMed ID: 27073727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational approach to the clinical protocol design for drug combinations: a review.
    Chang TT; Chou TC
    Acta Paediatr Taiwan; 2000; 41(6):294-302. PubMed ID: 11198934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical versus clinical drug combination studies.
    Chou TC
    Leuk Lymphoma; 2008 Nov; 49(11):2059-80. PubMed ID: 19021049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis.
    Sueke H; Kaye SB; Neal T; Hall A; Tuft S; Parry CM
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4151-5. PubMed ID: 20335613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antistaphylococcal effect of enterocin AS-48 in bakery ingredients of vegetable origin, alone and in combination with selected antimicrobials.
    Viedma PM; Abriouel H; Omar NB; López RL; Gálvez A
    J Food Sci; 2009 Sep; 74(7):M384-9. PubMed ID: 19895485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro potency and combination testing of antimicrobial agents against Neisseria gonorrhoeae.
    Bharat A; Martin I; Zhanel GG; Mulvey MR
    J Infect Chemother; 2016 Mar; 22(3):194-7. PubMed ID: 26603424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxytyrosol: a new class of microbicide displaying broad anti-HIV-1 activity.
    Bedoya LM; Beltrán M; Obregón-Calderón P; García-Pérez J; de la Torre HE; González N; Pérez-Olmeda M; Auñón D; Capa L; Gómez-Acebo E; Alcamí J
    AIDS; 2016 Nov; 30(18):2767-2776. PubMed ID: 27677167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance patterns of Campylobacter from feedlot cattle*.
    Englen MD; Fedorka-Cray PJ; Ladely SR; Dargatz DA
    J Appl Microbiol; 2005; 99(2):285-91. PubMed ID: 16033459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synergistic apoptotic effect of the combination of diosgenin and TRAIL on non-small-cell lung cancer cell line A549 evaluated with the Chou-Talalay method].
    He Y; Wang JS; Zhang P; Zhang WJ; Huang QL; Hua ZC
    Yao Xue Xue Bao; 2013 Jan; 48(1):45-51. PubMed ID: 23600140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of antibiotic and antimicrobial biocide susceptibility data in clinical isolates of methicillin-sensitive Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa between 1989 and 2000.
    Lambert RJ
    J Appl Microbiol; 2004; 97(4):699-711. PubMed ID: 15357719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin.
    Tsuji BT; Rybak MJ
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):73-7. PubMed ID: 16368477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus.
    Jacqueline C; Navas D; Batard E; Miegeville AF; Le Mabecque V; Kergueris MF; Bugnon D; Potel G; Caillon J
    Antimicrob Agents Chemother; 2005 Jan; 49(1):45-51. PubMed ID: 15616274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus.
    Khan IA; Mirza ZM; Kumar A; Verma V; Qazi GN
    Antimicrob Agents Chemother; 2006 Feb; 50(2):810-2. PubMed ID: 16436753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antimicrobial synergy testing of coagulase-negative staphylococci isolated from prosthetic joint infections using Etest and with a focus on rifampicin and linezolid.
    Hellmark B; Unemo M; Nilsdotter-Augustinsson A; Söderquist B
    Eur J Clin Microbiol Infect Dis; 2010 May; 29(5):591-5. PubMed ID: 20221891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of antibacterial activity of topical antimicrobials against methicillin-resistant Staphylococcus aureus].
    Cui S; Han L; Xiao S; Chen X; Chang Q; Liu Y; Zhang X
    Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):21-4. PubMed ID: 24684985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane damage to bacteria caused by single and combined biocides.
    Johnston MD; Hanlon GW; Denyer SP; Lambert RJ
    J Appl Microbiol; 2003; 94(6):1015-23. PubMed ID: 12752809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.